Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1404281 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $3.55 · Day −1.93% · Mkt cap $294M · 1Y +35.5% · Off 52W high −22.8% · Vol (1Y) 85.7% Price2023-08-21 → 2026-08-19 ELDN close: $1.32 on 2023-08-21 to $3.55 on 2026-08-19. Split-adj closes · 240 of 1,377 · price returnⓘ At a glance | Short interest7.6% of sh out | | Days to cover6.5d | | 13F net flow (QoQ)−0.56% | | Top-10 13F concentration66.9% | | Next report (est.)2026-11-13 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$98.6M | | ROE−63.6% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+135.1% | | 1Y+35.5% | | 3Y+168.9% | | 5Y−43.7% | | Since incept. (ann.)−26.1% |
Total return · from 2021-02-22ⓘ Risk | Ann. volatility (1Y)85.7% | | Ann. volatility (3Y)79.5% | | Sharpe (1Y)0.87 | | Sharpe (3Y)0.82 | | Max drawdown (1Y)−68.1% | | Max drawdown (3Y)−73.8% | | Beta (3Y vs SPY)0.16 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BVF INC/IL | 6.3M | $19M | 8.30% | +0.0% | | BlackRock, Inc. | 4.4M | $13M | 5.78% | +20.8% | | Defilade Capital Management, L.P. | 3.6M | $11M | 4.70% | +8.3% | | VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | $10M | 4.34% | new | | Ensign Peak Advisors, Inc | 2.5M | $8M | 3.25% | +0.0% | | Zimmer Partners, LP | 1.9M | $6M | 2.47% | −21.4% | | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $6M | 2.36% | +26.0% | | SPHERA FUNDS MANAGEMENT LTD. | 1.8M | $5M | 2.34% | −16.9% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-13 | −$0.27 | — | — | — | | 2026-03-31 | 2026-05-13 | −$0.33 | — | — | — | | 2025-09-30 | 2025-11-14 | −$0.21 | — | — | — | | 2025-06-30 | 2025-08-14 | −$0.13 | — | — | — |
As-reported XBRL · next 2026-11-13 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
